Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07740239) titled 'A COhort Study on Factors Leading to Vulnerability in Adult Patients With Serious Medical cOnditionS: the COSMOS-I Trial' on July 28.
Study Type: Observational
Primary Sponsor: Tampere University Hospital
Condition:
Pelvic Fracture
Prostate Cancer
Lung Cancer
Brain Metastasis
Chronic Subdural Hematoma
Intervention:
Other: Test set to determine vulnerability
Recruitment Status: Recruiting
Date of First Enrollment: November 13, 2024
Target Sample Size: 2050
Countries of Recruitment:
Finland
To know more, visit https://clinicaltrials.gov/study/NCT07740239
Disclaimer: Curated by HT Syndication....